SCHEMBL9108619

SCHEMBL9108619

C=CCN1C(=O)NC(=O)C(=CN(C)C)C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 13/20 0.56
MAPT P10636 12/20 0.56
MEN1 O00255 10/20 0.56
CYP1A2 P05177 1/20 0.56
ALDH1A1 P00352 13/20 0.52
LMNA P02545 5/20 0.52
HTT P42858 2/20 0.52
GAA P10253 1/20 0.52
KDM4E B2RXH2 4/20 0.51
NPSR1 Q6W5P4 2/20 0.51
POLB P06746 6/20 0.50
HPGD P15428 4/20 0.50
PKM P14618 4/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
MAPK1 P28482 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4C Q9H3R0 2/20 0.50
MITF O75030 1/20 0.50
USP2 O75604 1/20 0.50
GFER P55789 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10356283 0.77 MAPT (0.50) KMT2AMAPTMEN1CYP1A2ALDH1A1
SCHEMBL26948723 0.73 MAPT (0.48) KMT2AMAPTMEN1CYP1A2ALDH1A1
SCHEMBL14900321 0.72 MAPT (0.49) KMT2AMAPTMEN1ALDH1A1LMNA
SCHEMBL13479510 0.71 KMT2A (0.71) KMT2AMAPTMEN1CYP1A2ALDH1A1
SCHEMBL18481368 0.70 MAPT (0.45) KMT2AMAPTMEN1CYP1A2ALDH1A1
SCHEMBL13479537 0.69 KMT2A (0.64) KMT2AMAPTMEN1CYP1A2ALDH1A1
SCHEMBL18481370 0.68 MAPT (0.47) KMT2AMAPTMEN1CYP1A2ALDH1A1
SCHEMBL16728132 0.67 MAPT (1.00) KMT2AMAPTMEN1CYP1A2ALDH1A1
SCHEMBL26948752 0.67 MAPT (0.43) KMT2AMAPTMEN1CYP1A2ALDH1A1
SCHEMBL13186611 0.65 KMT2A (0.53) KMT2AMAPTMEN1CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9249106-B2 Substituted hydrazide compounds and use thereof SHENYANG J & HEALTH PHARMACEUTICAL CO., LTD. (CN) 2016-02-02 US disclosed
EP-2468730-A1 SUBSTITUTED HYDRAZIDE COMPOUNDS AND APPLICATION THEREOF Shenyang J & Health Pharmaceutical Co., Ltd. (CN) 2012-06-27 EP disclosed
US-20120142921-A1 SUBSTITUTED HYDRAZIDE COMPOUNDS AND USE THEREOF SHENYANG J & HEALTH PHARMACEUTICAL CO., LTD. (CN) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142921-A1 SUBSTITUTED HYDRAZIDE COMPOUNDS AND USE THEREOF SLC5A1, VHL, AKR1A1 KMT2A 1370/4885MAPT 3410/4885MEN1 1487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.